Drug Shortage Report for BESIVANCE
Report ID | 29526 |
Drug Identification Number | 02336847 |
Brand name | BESIVANCE |
Common or Proper name | BESIVANCE |
Company Name | BAUSCH & LOMB INC |
Market Status | MARKETED |
Active Ingredient(s) | BESIFLOXACIN |
Strength(s) | 0.6% |
Dosage form(s) | SUSPENSION |
Route of administration | OPHTHALMIC |
Packaging size | N/A |
ATC code | S01AE |
ATC description | ANTIINFECTIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2017-10-31 |
Estimated end date | |
Actual end date | 2018-07-06 |
Shortage status | Resolved |
Updated date | 2018-07-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1400 N GOODMAN STREET ROCHESTER, NEW YORK UNITED STATES 14609 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2018-07-09 | French | Compare |
v13 | 2018-07-09 | English | Compare |
v12 | 2018-06-29 | French | Compare |
v11 | 2018-06-29 | English | Compare |
v10 | 2018-06-22 | French | Compare |
v9 | 2018-06-22 | English | Compare |
v8 | 2018-05-11 | French | Compare |
v7 | 2018-05-11 | English | Compare |
v6 | 2018-04-19 | French | Compare |
v5 | 2018-04-19 | English | Compare |
v4 | 2018-03-13 | French | Compare |
v3 | 2018-03-13 | English | Compare |
v2 | 2017-11-17 | French | Compare |
v1 | 2017-11-17 | English | Compare |
Showing 1 to 14 of 14